Letter: Methodological Considerations in Comparing Liver Outcomes of Glucagon‐Like Peptide‐1 Receptor and Sodium Glucose Cotransporter‐2 Inhibitors

Cheng‐Hsien HungChun‐Ting LinJames Cheng‐Chung Wei2026-02-052026-02-052025-04-1410.1111/apt.70049https://scholars.csmu.edu.tw/handle/123456789/5217Letter: Methodological Considerations in Comparing Liver Outcomes of Glucagon‐Like Peptide‐1 Receptor and Sodium Glucose Cotransporter‐2 Inhibitorsjournal-article